Zhu L - Search Results

1

Modulation of cellular metabolism by protein crotonylation regulates pancreatic cancer progression.

Zheng Y, Zhu L, Qin ZY, Guo Y, Wang S, Xue M, Shen KY, Hu BY, Wang XF, Wang CQ, Qin LX, Dong QZ. Zheng Y, et al. Among authors: zhu l. Cell Rep. 2023 Jul 25;42(7):112666. doi: 10.1016/j.celrep.2023.112666. Epub 2023 Jun 21. Cell Rep. 2023. PMID: 37347667 Free article.

2

The association between KLF4 as a tumor suppressor and the prognosis of hepatocellular carcinoma after curative resection.

Xue M, Zhou C, Zheng Y, Zhang Z, Wang S, Fu Y, Atyah M, Xue X, Zhu L, Dong Q, Jia H, Ren N, Hu R. Xue M, et al. Among authors: zhu l. Aging (Albany NY). 2020 Aug 5;12(15):15566-15580. doi: 10.18632/aging.103592. Epub 2020 Aug 5. Aging (Albany NY). 2020. PMID: 32756012 Free PMC article.

3

Isolation and characterization of exosomes for cancer research.

Zhu L, Sun HT, Wang S, Huang SL, Zheng Y, Wang CQ, Hu BY, Qin W, Zou TT, Fu Y, Shen XT, Zhu WW, Geng Y, Lu L, Jia HL, Qin LX, Dong QZ. Zhu L, et al. Among authors: zhu ww. J Hematol Oncol. 2020 Nov 10;13(1):152. doi: 10.1186/s13045-020-00987-y. J Hematol Oncol. 2020. PMID: 33168028 Free PMC article. Review.

4

The molecular biology of pancreatic adenocarcinoma: translational challenges and clinical perspectives.

Wang S, Zheng Y, Yang F, Zhu L, Zhu XQ, Wang ZF, Wu XL, Zhou CH, Yan JY, Hu BY, Kong B, Fu DL, Bruns C, Zhao Y, Qin LX, Dong QZ. Wang S, et al. Among authors: zhu l, zhu xq. Signal Transduct Target Ther. 2021 Jul 5;6(1):249. doi: 10.1038/s41392-021-00659-4. Signal Transduct Target Ther. 2021. PMID: 34219130 Free PMC article. Review.

5

Inhibition of EGFR Overcomes Acquired Lenvatinib Resistance Driven by STAT3-ABCB1 Signaling in Hepatocellular Carcinoma.

Hu B, Zou T, Qin W, Shen X, Su Y, Li J, Chen Y, Zhang Z, Sun H, Zheng Y, Wang CQ, Wang Z, Li TE, Wang S, Zhu L, Wang X, Fu Y, Ren X, Dong Q, Qin LX. Hu B, et al. Among authors: zhu l. Cancer Res. 2022 Oct 17;82(20):3845-3857. doi: 10.1158/0008-5472.CAN-21-4140. Cancer Res. 2022. PMID: 36066408 Free PMC article.

6

Implications of hydrogen sulfide in colorectal cancer: Mechanistic insights and diagnostic and therapeutic strategies.

Lin H, Yu Y, Zhu L, Lai N, Zhang L, Guo Y, Lin X, Yang D, Ren N, Zhu Z, Dong Q. Lin H, et al. Among authors: zhu z, zhu l. Redox Biol. 2023 Feb;59:102601. doi: 10.1016/j.redox.2023.102601. Epub 2023 Jan 7. Redox Biol. 2023. PMID: 36630819 Free PMC article. Review.

7

System Analysis Based on Lipid-Metabolism-Related Genes Identifies AGT as a Novel Therapy Target for Gastric Cancer with Neoadjuvant Chemotherapy.

Zhu L, Ma M, Zhang L, Wang S, Guo Y, Ling X, Lin H, Lai N, Lin S, Du L, Dong Q. Zhu L, et al. Pharmaceutics. 2023 Mar 2;15(3):810. doi: 10.3390/pharmaceutics15030810. Pharmaceutics. 2023. PMID: 36986671 Free PMC article.

8

Single-cell mapping reveals several immune subsets associated with liver metastasis of pancreatic ductal adenocarcinoma.

Zhang Z, Zhu XQ, Yang F, Lai NN, Zhu L, Cole K, Hu BY, Li TE, Zhu Y, Zhang LM, Wang S, Zheng Y, Mao H, Zhao Y, Bruns C, Vago R, Tu B, Wong JWH, Fu DL, Qin LX, Dong QZ. Zhang Z, et al. Among authors: zhu y, zhu l, zhu xq. Med. 2023 Oct 13;4(10):728-743.e7. doi: 10.1016/j.medj.2023.07.010. Epub 2023 Aug 25. Med. 2023. PMID: 37633269

9

Disruption of MerTK increases the efficacy of checkpoint inhibitor by enhancing ferroptosis and immune response in hepatocellular carcinoma.

Wang S, Zhu L, Li T, Lin X, Zheng Y, Xu D, Guo Y, Zhang Z, Fu Y, Wang H, Wang X, Zou T, Shen X, Zhang L, Lai N, Lu L, Qin L, Dong Q. Wang S, et al. Among authors: zhu l. Cell Rep Med. 2024 Feb 20;5(2):101415. doi: 10.1016/j.xcrm.2024.101415. Cell Rep Med. 2024. PMID: 38382467 Free PMC article.

10

Cirrhotic-extracellular matrix attenuates aPD-1 treatment response by initiating immunosuppressive neutrophil extracellular traps formation in hepatocellular carcinoma.

Shen XT, Xie SZ, Zheng X, Zou TT, Hu BY, Xu J, Liu L, Xu YF, Wang XF, Wang H, Wang S, Zhu L, Yu KK, Zhu WW, Lu L, Zhang JB, Chen JH, Dong QZ, Yang LY, Qin LX. Shen XT, et al. Among authors: zhu ww, zhu l. Exp Hematol Oncol. 2024 Feb 22;13(1):20. doi: 10.1186/s40164-024-00476-9. Exp Hematol Oncol. 2024. PMID: 38388466 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

27,434 results

Search Page